Komo

Generic and specialty medicines company

What is Teva Pharmaceutical?

Teva Pharmaceutical is a generic and specialty medicines company company serving enterprise, commercial, consumer, healthcare, financial, real estate, or regulated-market customers.

Category
Generic and specialty medicines company
Headquarters
Tel Aviv, Israel
Founded
See official company history
Employees
See latest annual report and company filings
Total funding
Public company
Status
Public company; NYSE/TASE: TEVA

What is Teva Pharmaceutical?

Teva Pharmaceutical is a generic and specialty medicines company company headquartered in Tel Aviv, Israel. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.

Teva Pharmaceutical is a generic and specialty medicines company company headquartered in Tel Aviv, Israel. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.

For sellers, Teva Pharmaceutical should be mapped as a scaled public-company account. The best timing signals are earnings commentary, capital spending, hiring clusters, product launches, acquisitions, facility investments, and leadership changes.

What does Teva Pharmaceutical offer?

Teva Pharmaceutical's profile centers on Generic medicines, Specialty medicines, Biosimilars, API manufacturing.

  • Generic medicines· Generic and specialty medicines company
  • Specialty medicines· Generic and specialty medicines company
  • Biosimilars· Generic and specialty medicines company
  • API manufacturing· Generic and specialty medicines company
  • Global supply chain· Generic and specialty medicines company
  • Neuroscience medicines· Generic and specialty medicines company

How does Teva Pharmaceutical make money?

Teva Pharmaceutical makes money through commercial activity tied to generic and specialty medicines company.

Teva Pharmaceutical monetizes through the model common to generic and specialty medicines company: product sales, recurring services, contracts, leases, subscriptions, transaction volume, servicing, investment management, or usage depending on the operating unit.

Sales angles should connect to measurable priorities such as margin, growth, occupancy, compliance, retention, automation, risk reduction, data quality, customer experience, or field productivity.

Who leads Teva Pharmaceutical?

Teva Pharmaceutical's named executives should be verified on the official leadership or investor-relations page before outreach.

  • Teva Pharmaceutical executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
  • Teva Pharmaceutical finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, capital allocation, and budget discipline.
  • Teva Pharmaceutical operations or technology leadershipOperations, product, technology, security, or commercial leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operating-improvement purchases.

How do you contact Teva Pharmaceutical's leadership?

Teva Pharmaceutical should be contacted through official investor, media, partner, support, or sales routes unless a named executive publishes a direct address.

Email formatcontact via https://www.tevapharm.com

How is Teva Pharmaceutical funded?

Teva Pharmaceutical's current status is Public company; NYSE/TASE: TEVA.

Teva Pharmaceutical's capital profile is best understood through its current public-company status: Public company; NYSE/TASE: TEVA. For public companies, financing and budget signals are usually found in annual reports, quarterly results, debt disclosures, buybacks, acquisitions, capital expenditure plans, and management commentary rather than venture funding rounds.

Before outreach, verify the latest status on the company's investor-relations page and current exchange filings.

How did Teva Pharmaceutical get here?

Teva Pharmaceutical's history should be read through founding, scale-up, public-market ownership, and current product or market focus.

  1. FoundingTeva Pharmaceutical is foundedThe company begins building in generic and specialty medicines company.
  2. Scale-upCommercial footprint expandsTeva Pharmaceutical broadens its product, customer, distribution, or geographic reach.
  3. Public marketsPublic company; NYSE/TASE: TEVAPublic-company ownership shapes reporting, procurement, and operating priorities.
  4. 2025Scaled operating profileThe company operates with specialized teams and repeatable buying centers.
  5. June 2026Current profile refreshedProfile generated from official domain, public-company status, and source references.

Who are Teva Pharmaceutical's competitors?

Teva Pharmaceutical competes with larger incumbents and focused specialists in generic and specialty medicines company.

  • PfizerGlobal pharmaceutical company.
  • RochePharmaceuticals and diagnostics company.
  • NovartisGlobal medicines company.
  • SanofiPharmaceutical and vaccines company.
  • GSKBiopharmaceutical company.

Teva Pharmaceutical — frequently asked questions

Agent CTA Background

Revenue work. On autopilot.

Start Free TrialBuilt for revenue teams who care about quality.